Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses

Carl Zeiss Meditec

Status: Completed

Conditions: Cataract

Treatments: Device: AT LISA tri 839MP

Study type: Interventional

Funder types: Industry

Identifiers

NCT01731743

839 MP HEN 402-11

Details and patient eligibility

About

The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.

Full description

After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction.

A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.

Enrollment: 107 patients

Sex: All

Ages: 50+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Man or woman, over 50 years of age
• Bilateral implantation of a trifocal intraocular lens
• Capsular bag implantation

Exclusion criteria

• Existing ocular pathology
• Surgical complications
• Corneal astigmatism ≥ 1.0D

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

107 participants in 1 patient group

implantation of a trifocal IOL (AT LISA tri 839MP)

Other group

Treatment:

Device: AT LISA tri 839MP